Thermogenesis Holdings, Inc. (THMO) News

Thermogenesis Holdings, Inc. (THMO): $1.21

0.17 (-12.32%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Filter THMO News Items

THMO News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

THMO News Highlights

  • THMO's 30 day story count now stands at 4.
  • Over the past 4 days, the trend for THMO's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
  • The most mentioned tickers in articles about THMO are CELL and GENE.

Latest THMO News From Around the Web

Below are the latest news stories about THERMOGENESIS HOLDINGS INC that investors may wish to consider to help them evaluate THMO as an investment opportunity.

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q2 2023 Earnings Call Transcript

ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Q2 2023 Earnings Call Transcript August 11, 2023 Operator: Good day, and welcome to the ThermoGenesis Holdings conference call and webcast to review financial and operating results for the second quarter ended June 30, 2023. [Operator Instructions]. As a reminder, this conference call is being recorded. I would now like to […]

Yahoo | August 12, 2023

Q2 2023 Thermogenesis Holdings Inc Earnings Call

Q2 2023 Thermogenesis Holdings Inc Earnings Call

Yahoo | August 11, 2023

ThermoGenesis Holdings Announces Second Quarter 2023 Financial Results and Provides Corporate Update

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the second quarter ended June 30, 2023, and provided a corporate business update.

Yahoo | August 10, 2023

ThermoGenesis Holdings to Announce Financial Results for the Second Quarter ended June 30, 2023 and Provide a Corporate Strategic Update

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the second quarter ended June 30, 2023, and provide a corporate strategic update on Thursday, August 10, 2023, after the close of trading. A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET.

Yahoo | August 8, 2023

ThermoGenesis Expands Board of Directors with the Appointments of Dr. Biao Xi and Dr. James Xu

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced the appointments of Biao Xi, Ph.D. and James Xu, Esq., DBA, PsyD., J.D., CPA to its Board, effective July 17, 2023. Both are independent directors. The appointments expand ThermoGenesis' Board to seven members.

Yahoo | July 17, 2023

Analysts Expect Breakeven For ThermoGenesis Holdings, Inc. (NASDAQ:THMO) Before Long

We feel now is a pretty good time to analyse ThermoGenesis Holdings, Inc.'s ( NASDAQ:THMO ) business as it appears the...

Yahoo | July 7, 2023

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

It's time for another dive into the latest pre-market stock movers as we check out all of the news moving shares on Tuesday morning!

William White on InvestorPlace | June 6, 2023

Q1 2023 Thermogenesis Holdings Inc Earnings Call

Q1 2023 Thermogenesis Holdings Inc Earnings Call

Yahoo | May 16, 2023

ThermoGenesis Holdings Announces First Quarter 2023 Financial Results and Provides Corporate Update

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today reported financial and operating results for the first quarter ended March 31, 2023 and provided a corporate strategic update.

Yahoo | May 15, 2023

ThermoGenesis Holdings to Announce Financial Results for the First Quarter Ended March 31, 2023 and Provide a Corporate Strategic Update

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company will release its financial results for the first quarter ended March 31, 2023 and provide a corporate strategic update on Monday, May 15, 2023, after the close of trading. A conference call and webcast will follow at 1:30 p.m. PT/ 4:30 p.m. ET.

Yahoo | May 10, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!